Books > Medicine > General issues
|
Buy Now
Progress in Drug Research (Paperback, Softcover reprint of the original 1st ed. 2000)
Loot Price: R1,640
Discovery Miles 16 400
|
|
Progress in Drug Research (Paperback, Softcover reprint of the original 1st ed. 2000)
Series: Progress in Drug Research, 55
Expected to ship within 10 - 15 working days
|
Hepatitis C virus (HCV) was first identified in 1989 as the
etiologic agent of non-A, non-B hepatitis [1] and is currently
recognized as the leading cause of chronic liver disease worldwide.
In contrast to hepatitis B virus infection, in which only about 5%
of adult infections become chronic, more than 80% of HCV-infected
patients develop chronic hepatitis. Moreover, 20-50% of those
persistently infected with HCV will develop liver cirrhosis and
hepatocellu lar carcinoma (HCC) [2]. It is estimated that there are
10,000 deaths in the USA per year due to chronic liver failure or
HCC [3]. In addition, HCV dis 25-50% of all liver transplants in US
centers, and the ease is responsible for recurrence of HCV
infection following liver transplantation is universal [4].
Typically, HCV disease emerges after a 10-20 year period during
which symp toms, if they exist at all, are mild and non-specific.
Although the prevalence varies greatly among different countries,
it has been estimated that up to 170 million people (3% of the
world's population), are infected with HCV [5]. A recent study in
the USA found that 65% of all HCV-infected persons are 30 to 49
years old [6].
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
You might also like..
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.